LBSP Favicon
Open Day Recap

Open Day Recap

๐—ช๐—ต๐—ฎ๐˜ ๐—ต๐—ฎ๐—ฝ๐—ฝ๐—ฒ๐—ป๐˜€ ๐˜„๐—ต๐—ฒ๐—ป ๐—บ๐—ผ๐—ฟ๐—ฒ ๐˜๐—ต๐—ฎ๐—ป ๐Ÿญ๐Ÿฑ ๐˜€๐—ฐ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฎ๐—ป๐—ฑ ๐—ฏ๐—ถ๐—ผ๐˜๐—ฒ๐—ฐ๐—ต ๐—ผ๐—ฟ๐—ด๐—ฎ๐—ป๐—ถ๐˜€๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€ ๐—ผ๐—ฝ๐—ฒ๐—ป ๐˜๐—ต๐—ฒ๐—ถ๐—ฟ ๐—ฑ๐—ผ๐—ผ๐—ฟ๐˜€ ๐˜๐—ผ ๐˜๐—ต๐—ฒ ๐—ฝ๐˜‚๐—ฏ๐—น๐—ถ๐—ฐ?ย You get an Open Day that brings together over 2,400...

VarmX Secures IND Approval for Phase 3 Trial of VMX-C001 in Emergency Surgery

VarmX Secures IND Approval for Phase 3 Trial of VMX-C001 in Emergency Surgery

VarmX has received IND approval for its Phase 3 trial of VMXโ€‘C001, a recombinant factorโ€ฏX variant designed to neutralize FXaโ€‘inhibiting anticoagulants during emergency surgery. Backed by robust Phase 1 data and boosted by a โ‚ฌ15โ€ฏmillion EIC investment, this step positions VMXโ€‘C001 to meet a gap in urgent haemostasis care.

Key Region Leiden launch

Key Region Leiden launch

๐—›๐—ผ๐˜„ ๐—ฑ๐—ผ ๐˜„๐—ฒ ๐˜๐˜‚๐—ฟ๐—ป ๐˜€๐—ฐ๐—ถ๐—ฒ๐—ป๐˜๐—ถ๐—ณ๐—ถ๐—ฐ ๐—ธ๐—ป๐—ผ๐˜„๐—น๐—ฒ๐—ฑ๐—ด๐—ฒ ๐—ถ๐—ป๐˜๐—ผ ๐—ฟ๐—ฒ๐—ฎ๐—น ๐˜€๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป๐˜€, ๐—ณ๐—ฎ๐˜€๐˜๐—ฒ๐—ฟ, ๐˜€๐—บ๐—ฎ๐—ฟ๐˜๐—ฒ๐—ฟ, ๐—ฎ๐—ป๐—ฑ ๐˜๐—ผ๐—ด๐—ฒ๐˜๐—ต๐—ฒ๐—ฟ? Thatโ€™s the question Key Region Leiden is working to answer....

Progress Acquires Methnani & Associates to Expand Microbiology Expertise

Progress Acquires Methnani & Associates to Expand Microbiology Expertise

On July 3, 2025, Progress โ€“ Experts in Life Sciences announced its acquisition of Methnani & Associates, a consultancy specialised in pharmaceutical microbiology and sterility assurance. The move strengthens Progressโ€™s position in the field of quality and regulatory services for life sciences, with an emphasis on GMP compliance and contamination control.ย